The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.

AusPAR: Ardalicip / Ciptunec

AusPAR

AusPAR: Ardalicip / Ciptunec [PDF, 466.06 KB]

AusPAR: Ardalicip / Ciptunec [Word, 414.46 KB]

Attachment-Product information for Ardalicip [PDF, 914.92 KB]

Attachment-Product information for Ardalicip [Word, 689.35 KB]

Attachment-Product information for Ciptunec [PDF, 916.53 KB]

Attachment-Product information for Ciptunec [Word, 689.24 KB]

Device/Product Name

Ardalicip / Ciptunec

Active ingredients

adalimumab

AusPAR Date

27 April 2023

Published

10 May 2023

Submission Number

PM-2021-02447-1-3

Submission Type

New biosimilar entity

Decision

Approved